CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 35 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,673,374 | $21,893,000 | 2.58% |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $8,950,000 | 1.60% |
| Sofinnova Investments, Inc. | 3,606,707 | $21,496,000 | 1.24% |
| Omega Fund Management, LLC | 1,335,050 | $7,957,000 | 0.90% |
| Novo Holdings A/S | 2,170,100 | $12,934,000 | 0.57% |
| CLOUGH CAPITAL PARTNERS L P | 1,567,326 | $9,341,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 541,766 | $3,229,000 | 0.26% |
| RBF Capital, LLC | 68,834 | $410,000 | 0.02% |
| CAMBRIDGE TRUST CO | 24,609 | $147,000 | 0.01% |
| Ergoteles LLC | 26,427 | $158,000 | 0.00% |